A New Comprehensive Approach to Assess the Probability of Success of Development Programs Before Pivotal Trials-Reference-Cited by-同舟云学术

A New Comprehensive Approach to Assess the Probability of Success of Development Programs Before Pivotal Trials

Published:2021-12-13 Issue: Volume: Page:
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharmacol Ther

Author:

Hampson Lisa V.¹,Holzhauer Björn¹,Bornkamp Björn¹,Kahn Joseph²,Lange Markus R.¹,Luo Wen‐Lin²,Singh Pritibha¹,Ballerstedt Steffen¹,Cioppa Giovanni Della³

Affiliation:

1. Novartis Pharma AG Basel Switzerland

2. Novartis Pharmaceuticals Corporation East Hanover New Jersey USA

3. Clinical R&D Consultants srls Rome Italy

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2488

Reference42 articles.

1. The future of drug development: advancing clinical trial design;Orloff J.;Nat. Rev. Drug Discovery,2009

2. When is a seamless study desirable? Case studies from different pharmaceutical sponsors;Cuffe R.L.;Pharmaceut. Stat.,2014

3. Innovation in oncology clinical trial design;Verweij J.;Cancer Treat. Rev.,2019

4. Value‐driven project and portfolio management in the pharmaceutical industry: drug discovery versus drug development–Commonalities and differences in portfolio management practice;Bode‐Greuel K.M.;J. Commerc. Biotechnol.,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delta Inflation, Optimism Bias, and Uncertainty in Clinical Trials;Therapeutic Innovation & Regulatory Science;2024-09-06

2. Futility Interim Analysis Based on Probability of Success Using a Surrogate Endpoint;Pharmaceutical Statistics;2024-07-02

3. Assurance methods for designing a clinical trial with a delayed treatment effect;Statistics in Medicine;2024-06-16

4. Going beyond probability of success: Opportunities for statisticians to influence quantitative decision‐making at the portfolio level;Pharmaceutical Statistics;2024-01-11

5. Predicting Probability of Success for Phase III Trials via Propensity-Score-Based External Data Borrowing;Statistics in Biopharmaceutical Research;2023-12-12